Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines

Current Pharmaceutical Design

Volumn 20, Issue 2, 2014, Pages 189-200

  Leanza, Luigi ^a   O'Reilly, Paul ^b   Doyle, Anne ^b   Venturini, Elisa ^a   Zoratti, Mario ^a   Szegezdi, Eva ^b   Szabo, Ildiko ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Apoptosis; Chemotherapeutic drugs; Kv1.3 inhibitors; Mitochondria; Potassium channels

Indexed keywords

CERAMIDE; CISPLATIN; CLOFAZIMINE; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.3; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CORRELATIONAL STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE; TUMOR VOLUME; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CISPLATIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KV1.1 POTASSIUM CHANNEL; KV1.3 POTASSIUM CHANNEL; MITOCHONDRIA; NEOPLASMS; POTASSIUM CHANNEL BLOCKERS; RNA, MESSENGER; SPHINGOSINE; STAUROSPORINE; TUMOR BURDEN;

EID: 84892959692     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990032     Document Type: Article

References (95)

1. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004; 19: 285-92.
2. Lang F, Ritter M, Gamper N, et al. Cell volume in the regulation of cell proliferation and apoptotic cell death. Cell Physiol Biochem 2000; 10: 417-28.
3. + channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 2004; 448: 274-86.
4. Gutman GA, Chandy KG, Grissmer S, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005; 57: 473-508.
5. Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev 2009; 231: 59-87.
6. Stühmer W, Alves F, Hartung F, Zientkowska M, Pardo LA. Potassium channels as tumour markers. FEBS Lett 2006; 580: 2850-2.
7. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 2009; 16: 66-93.
8. Leanza L, Henry B, Sassi N, et al. Inhibitors of mitochondrial Kv1. 3 channels induce Bax/Bak-independent death of cancer cells. EMBO Mol Med 2012; 4: 577-93.
9. Jang SH, Choi SY, Ryu PS, Lee SY. Anti-proliferative effect of Kv1. 3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol 2011; 651: 26-32.
10. Szabò I, Zoratti M, Gulbins E. Contribution of voltage-gated potassium channels to the regulation of apoptosis. FEBS Lett 2010; 584: 2049-55.
11. + concentration decrease is not obligatory for apoptosis. J Biol Chem 2011; 286: 39823-8.
12. Szabò I, Leanza L, Gulbins E, Zoratti M. Physiology of potassium channels in the inner membrane of mitochondria. Pflugers Arch 2012; 463: 231-46.
13. Wang CL, Tsai ML, Wu SN. Evidence for mitoxantrone-induced block of inwardly rectifying K(+) channels expressed in the osteoclast precursor RAW 264. 7 cells differentiated with lipopolysaccharide. Cell Physiol Biochem 2012; 30: 687-701.
14. Wu SN, Yeh CC, Huang HC, Yang WH. Cholesterol depletion with (2-hydroxypropyl)-cyclodextrin modifies the gating of membrane electroporation-induced inward current in pituitary tumor GH3 cells: experimental and analytical studies. Cell Physiol Biochem 2011; 28: 959-68.
15. Jehle J, Schweizer PA, Katus HA, Thomas D. Novel roles for hERG K(+) channels in cell proliferation and apoptosis. Cell Death Dis 2011 Aug 18; 2: e193.
16. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009; 8: 982-1001.
17. Usman H, Mathew MK Potassium channel regulator KCNRG regulates surface expression of Shaker-type potassium channels. Biochem Biophys Res Commun 2010; 391: 1301-5.
18. Zhu J, Yan J, Thornhill WB. N-glycosylation promotes the cell surface expression of Kv1. 3 potassium channels. FEBS J 2012; 279: 2632-44.
19. Solé L, Roura-Ferrer M, Pérez-Verdaguer M, et al. KCNE4 suppresses Kv1. 3 currents by modulating trafficking, surface expression and channel gating. J Cell Sci 2009; 122: 3738-48.
20. Nguyen HM, Galea CA, Schmunk G, et al. Intracellular trafficking of the KV1. 3 potassium channel is regulated by the pro-domain of a matrix metalloprotease. J Biol Chem 2013 Jan 11, in press.
21. + channel in T lymphocytes upon Fas stimulation. J Biol Chem 1996; 271: 20465-9.
22. Lang F, Föller M, Lang K, et al. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol 2007; 428: 209-25.
23. McFerrin MB, Turner KL, Cuddapah VA, Sontheimer H. Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death. Am J Physiol Cell Physiol 2012; 303: C1070-8.
24. Szabó I, Bock J, Grassmé H, et al. Mitochondrial potassium channel Kv1. 3 mediates Bax-induced apoptosis in lymphocytes. Proc Natl Acad Sci USA 2008; 105: 14861-6.
25. Koeberle PD, Wang Y, Schlichter LC. Kv1. 1 and Kv1. 3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 2010; 17: 134-44.
26. Hu CL, Zeng XM, Zhou MH, Shi YT, Cao H, Mei YA. Kv1. 1 is associated with neuronal apoptosis and modulated by protein kinase C in the rat cerebellar granule cell. J Neurochem 2008; 106: 1125-37.
27. Shen QJ, Zhao YM, Cao DX, Wang XL. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons. J Neurosci Res 2009; 87: 3153-60.
28. Lee AL, Dumas TC, Tarapore PE, et al. Potassium channel gene therapy can prevent neuron death resulting from necrotic and apoptotic insults. J Neurochem 2003; 86: 1079-88.
29. + channel gene transcription in primary pulmonary hypertension. Lancet 1998; 351: 726-7.
30. + currents and mitochondrial membrane depolarization in artery myocyte apoptosis. Am J Physiol Lung Cell Mol Physiol 2001; 281: L887-94.
31. Brevnova EE, Platoshyn O, Zhang S, Yuan JX. Overexpression of human KCNA5 increases IK(V) and enhances apoptosis. Am J Physiol Cell Physiol 2004; 287: C715-22.
32. Caouette D, Dongmo C, Berube J, Fournier D, Daleau P. Hydrogen peroxide modulates the Kv1. 5 channel expressed in a mammalian cell line. Naunyn Schmiedebergs Arch Pharmacol 2003; 368: 479-86.
33. Michelakis ED, Hampl V, Nsair A, et al. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 2002; 90: 1307-15.
34. Chen Y, Sánchez A, Rubio ME, Kohl T, Pardo LA, Stühmer W. Functional K(v)10. 1 channels localize to the inner nuclear membrane. PLoS One 2011; 6: e19257.
35. + channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 2002; 62: 4843-48.
36. + channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol 2004; 286: L49-67.
37. Liu C, Cotten JF, Schuyler JA, et al. Protective effects of TASK-3 (KCNK9) and related 2P K channels during cellular stress. Brain Res 2005; 1031: 164-73.
38. Nam JH, Shin DH, Zheng H, et al. Expression of TASK-2 and its upregulation by B cell receptor stimulation in WEHI-231 mouse immature B cells. Am J Physiol Cell Physiol 2011; 300: C1013-22.
39. Arcangeli A, Pillozzi S, Becchetti A. Targeting ion channels in leukemias: a new challenge for treatment. Curr Med Chem 2012; 19: 683-96.
40. Felipe A, Bielanska J, Comes N, et al. Targeting the voltagedependent K(+) channels Kv1. 3 and Kv1. 5 as tumor biomarkers for cancer detection and prevention. Curr Med Chem 2012; 19: 661-74.
41. Szabò I, Soddemann M, Leanza L, Zoratti M, Gulbins E. Singlepoint mutations of a lysine residue change function of Bax and BclxL expressed in Bax-and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ 2011; 18: 427-38.
42. Cheng Y, Gulbins E, Siemen D. Activation of the permeability transition pore by Bax via inhibition of the mitochondrial BK channel. Cell Physiol Biochem 2011; 27: 191-200.
43. Leanza L, Zoratti M, Gulbins E, Szabò I. Induction of apoptosis in macrophages via Kv1. 3 and Kv1. 5 potassium channels. Curr Med Chem 2012; 19: 5394-404.
44. Quast SA, Berger A, Buttstädt N, Friebel K, Schönherr R, Eberle J. General Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMAC. PLoS One 2012; 7: e39290.
45. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
46. Li Q, Birkbak NJ, Gyorffy B, Szallasi Z, Eklund AC. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics 2011; 12: 474.
47. R Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www. R-project. org/.
48. Wright Ken. Corrgram package (2012). URL http://cran. rproject. org/web/packages/corrgram/index. html/.
49. th Edition. W. W. Norton & Company, 2007.
50. Ghazalpour A, Bennett B, Petyuk VA, et al. Comparative analysis of proteome and transcriptome variation in mouse. PLoS Genet 2011; 7: e1001393.
51. Dimanche-Boitrel MT, Rebillard A, Gulbins E. Ceramide in chemotherapy of tumors. Recent Pat Anticancer Drug Discov 2011; 6: 284-93.
52. Senkal CE, Ponnusamy S, Rossi MJ, et al. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo, J. Pharmacol. Exp. Ther 2006; 317: 1188-99.
53. Carpinteiro A, Dumitru C, Schenck M, Gulbins E. Ceramideinduced cell death in malignant cells. Cancer Lett 2008; 264: 1-10.
54. Henry B, Möller C, Dimanche-Boitrel MT, Gulbins E, Becker KA. Targeting the ceramide system in cancer. Cancer Lett 2011.
55. Ferrari D, Pinton P, Campanella M, et al. Functional and structural alterations in the endoplasmic reticulum and mitochondria during apoptosis triggered by C2-ceramide and CD95/APO-1/FAS receptor stimulation. Biochem Biophys Res Commun 2010; 391: 575-81.
56. Gulbins E, Szabo I, Baltzer K, Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc Natl Acad Sci USA; 1997; 94: 7661-6.
57. Bock J, Szabó I, Gamper N, Adams C, Gulbins E. Ceramide inhibits the potassium channel Kv1. 3 by the formation of membrane platforms. Biochem Biophys Res Commun 2003; 305: 890-7.
58. Szabò I, Adams C, Gulbins E. Ion channels and membrane rafts in apoptosis. Pflugers Arch 2004; 448: 304-12.
59. Chapman H, Ramström C, Korhonen L, et al. Downregulation of the HERG (KCNH2) K(+) channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation. J Cell Sci 2005; 118: 5325-34.
60. + channels in neoplastic hematopoietic cells. J Biol Chem 2002; 277: 18528-34.
61. Gulbins E, Sassi N, Grassmè H, Zoratti M, Szabò I. Role of Kv1. 3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim Biophys Acta 2010; 1797: 1251-9.
62. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
63. Preussat K, Beetz C, Schrey M, et al. Expression of voltage-gated potassium channels Kv 1. 3 and Kv 1. 5 in human gliomas. Neurosci Lett 2003; 346: 33-6.
64. Abdul M, Hoosein N. Reduced Kv 1. 3 potassium channel expression in human prostate cancer. J Membr Biol 2006; 214: 99-102.
65. + channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pflugers Arch 2003; 446: 559-71.
66. Abdul M, Santo A, Hoosein N. Activity of potassium channel blockers in breast cancer. Anticancer Res 2003; 23: 3347-51.
67. + channel subunit as potential diagnostic marker and therapeutic target for breast cancer. BMB Reports 2009; 42: 535-39.
68. Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2002; 9: 961-4.
69. Bielanska J, Hernàndez-Losa J, Pérez-Verdaguer M, et al. Voltagedependent potassium channels Kv1. 3 and Kv1. 5 in human cancer. Curr Cancer Drug Targets 2009; 9: 904-14.
70. Brevet M, Fucks D, Chatelain D, et al. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1. 3 gene promoter methylation. Pancreas 2009; 38: 649-54.
71. +) channel Kv1. 3 and Kv1. 5 expression correlates with leiomyosarcoma aggressiveness. Oncol Lett 2012; 4: 227-30.
72. Jang SH, Ryu PD, Lee SY. Dendrotoxin-suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice. J Vet Sci 2011; 12: 35-40.
73. +) channels. EMBO J 1999; 18: 5540-7.
74. Ousingsawat J, Spitzner M, Puntheeranurak S, et al. Expression of voltage-gated potassium channels in human and mouse colonic carcinoma. Clin Cancer Res 2007; 13: 824-31.
75. +) channels in cell proliferation and apoptosis. Cell Death Dis 2011; 2: e193.
76. Pillozzi S, Brizzi MF, Balzi M, et al. HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. Leukemia 2002; 16: 1791-98.
77. + channel and cytoprotective properties of 4-piperidinomethyl-2-isopropyl-5-methylphenol. J Pharm Pharmacol 2007; 59: 679-85.
78. + channels and SDF-1 in acute leukemic cell migration. Exp Cell Res 2009; 315: 2256-64.
79. + current during the differentiation of ML-1 human myeloblastic leukemia cells. J Membr Biol 1993; 132: 267-74.
80. + channels in normal and cancerous human breast. Histol Histopathol 2008; 23: 965-72.
81. + channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol 2008; 221: 1-6.
82. + channel function in the human mammary carcinoma cell line MCF-7. Oncol Rep 2008; 19: 1511-6.
83. Hammadi M, Chopin V, Matifat F, et al. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol 2012; 227: 3837-46.
84. 2+ influx in carcinoma cells of colon cancer. Life Sci 1999; 65: 55-62.
85. Lastraioli E, Guasti L, Crociani O, et al. herg1 gene and HERG1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res 2004; 64: 606-11.
86. + channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemother Pharmacol 2005; 56: 212-20.
87. Bortner CD, Cidlowski JA. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 2007; 462: 176-88.
88. Yu SP. Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol 2003; 70: 363-86.
89. Wang X, Xiao AY, Ichinose T, Yu SP. Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J Pharmacol. Exp. Ther 2000; 295: 524-30.
90. Wei L, Yu SP, Gottron F, Snider BJ, Zipfel GJ, Choi DW. (2003). Potassium channel blockers attenuate hypoxia-and ischemiainduced neuronal death in vitro and in vivo. Stroke 2003; 34: 1281-6.
91. Yu SP, Yeh CH, Sensi SL, et al. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997; 278: 114-7.
92. Leanza L, Trentin L, Becker KA, Frezzato F, Zoratti M, Gulbins E, Szabò I. Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1. 3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. Leukemia 2013; 27: 1782-1785.
93. Vennekamp J, Wulff H, Beeton C, et al. Kv1. 3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol 2004; 65: 1364-74.
94. Schmitz A, Sankaranarayanan A, Azam P, et al. Design of PAP-1, a selective small molecule Kv1. 3 blocker, for the suppression of effector memory T cells in autoimmune diseases. Mol Pharmacol 2005; 68: 1254-70.
95. Ren YR, Pan F, Parvez S, et al. Clofazimine inhibits human Kv1. 3 potassium channel by perturbing calcium oscillation in T lymphocytes. PLoS One 2008; 3: e4009.